Editorial: Comparative efficacy and cost associated with new agents in the treatment of non-small cell lung cancer (NSCLC).
Lung Cancer（2010）
关键词
NSCLC,Bevacizumab,Pemetrexed,Cost,Cost savings,Efficacy,Indirect comparison
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要